Another microfluidic platform designed to mimic the interstitium of the tumour consists of 3‐μm channels loaded with conditioned medium, GP33‐targeted CD8‐positive T cells and GP33‐positive cancer cells, respectively. The gene discussed is CD8A; the disease is cancer.